HK1175699A1 - - Google Patents
Info
- Publication number
- HK1175699A1 HK1175699A1 HK13102853.7A HK13102853A HK1175699A1 HK 1175699 A1 HK1175699 A1 HK 1175699A1 HK 13102853 A HK13102853 A HK 13102853A HK 1175699 A1 HK1175699 A1 HK 1175699A1
- Authority
- HK
- Hong Kong
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A000121A IT1397912B1 (it) | 2010-01-28 | 2010-01-28 | Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato. |
| PCT/IB2010/055560 WO2011092556A1 (en) | 2010-01-28 | 2010-12-03 | Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1175699A1 true HK1175699A1 (pt) | 2013-07-12 |
Family
ID=42288805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13102853.7A HK1175699A1 (pt) | 2010-01-28 | 2013-03-07 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8518988B2 (pt) |
| EP (1) | EP2528599B1 (pt) |
| JP (1) | JP2013518091A (pt) |
| KR (1) | KR101723532B1 (pt) |
| CN (1) | CN102665712B (pt) |
| AU (1) | AU2010344330B2 (pt) |
| BR (1) | BR112012018626B1 (pt) |
| CA (1) | CA2780432C (pt) |
| CY (1) | CY1115409T1 (pt) |
| DK (1) | DK2528599T3 (pt) |
| ES (1) | ES2489467T3 (pt) |
| HK (1) | HK1175699A1 (pt) |
| HR (1) | HRP20140610T1 (pt) |
| IT (1) | IT1397912B1 (pt) |
| MX (1) | MX2012008777A (pt) |
| PL (1) | PL2528599T4 (pt) |
| PT (1) | PT2528599E (pt) |
| RU (1) | RU2552354C2 (pt) |
| SI (1) | SI2528599T1 (pt) |
| WO (1) | WO2011092556A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104093403A (zh) * | 2012-02-03 | 2014-10-08 | 意大发马克股份公司 | 用于治疗肌肉萎缩症的二乙基-[6-(4-羟基氨基甲酰基-苯基-氨基甲酰氧基-甲基)-萘-2-基-甲基]-氯化铵 |
| ITUB20155193A1 (it) * | 2015-11-03 | 2017-05-03 | Italfarmaco Spa | Sospensioni orali di Givinostat fisicamente e chimicamente stabili |
| IT201900003281A1 (it) * | 2019-03-06 | 2020-09-06 | Chemi Spa | Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3574185B2 (ja) * | 1994-09-02 | 2004-10-06 | 小松屋化学株式会社 | 無水クエン酸トリマグネシウムおよびその製法 |
| IT1283637B1 (it) * | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
| WO1997046526A1 (en) * | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
| ITMI20030063A1 (it) * | 2003-01-17 | 2004-07-18 | Italfarmaco Spa | Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico. |
| MX2007013179A (es) * | 2005-04-22 | 2008-01-16 | Wyeth Corp | Formas cristalinas de clorhidrato de {[(2r)-7-(diclorofenil)-5- fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina. |
| WO2007022488A2 (en) * | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| KR100830003B1 (ko) * | 2006-10-31 | 2008-05-15 | 씨제이제일제당 (주) | 결정성 ｓ-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법 |
| WO2009019205A1 (en) * | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Crystalline form of a dihydropteridione derivative |
-
2010
- 2010-01-28 IT ITMI2010A000121A patent/IT1397912B1/it active
- 2010-12-03 EP EP10796492.6A patent/EP2528599B1/en active Active
- 2010-12-03 PL PL10796492T patent/PL2528599T4/pl unknown
- 2010-12-03 US US13/575,641 patent/US8518988B2/en active Active
- 2010-12-03 KR KR1020127013835A patent/KR101723532B1/ko active IP Right Grant
- 2010-12-03 AU AU2010344330A patent/AU2010344330B2/en active Active
- 2010-12-03 WO PCT/IB2010/055560 patent/WO2011092556A1/en active Application Filing
- 2010-12-03 BR BR112012018626-4A patent/BR112012018626B1/pt active IP Right Grant
- 2010-12-03 CN CN2010800535567A patent/CN102665712B/zh active Active
- 2010-12-03 ES ES10796492.6T patent/ES2489467T3/es active Active
- 2010-12-03 SI SI201030697T patent/SI2528599T1/sl unknown
- 2010-12-03 CA CA2780432A patent/CA2780432C/en active Active
- 2010-12-03 RU RU2012134703/04A patent/RU2552354C2/ru active
- 2010-12-03 JP JP2012550524A patent/JP2013518091A/ja active Pending
- 2010-12-03 MX MX2012008777A patent/MX2012008777A/es active IP Right Grant
- 2010-12-03 PT PT107964926T patent/PT2528599E/pt unknown
- 2010-12-03 DK DK10796492.6T patent/DK2528599T3/da active
-
2013
- 2013-03-07 HK HK13102853.7A patent/HK1175699A1/xx unknown
-
2014
- 2014-06-26 HR HRP20140610AT patent/HRP20140610T1/hr unknown
- 2014-08-04 CY CY20141100586T patent/CY1115409T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012018626B1 (pt) | 2021-06-08 |
| JP2013518091A (ja) | 2013-05-20 |
| PL2528599T3 (pl) | 2014-10-31 |
| HRP20140610T1 (hr) | 2014-08-15 |
| MX2012008777A (es) | 2012-09-07 |
| RU2012134703A (ru) | 2014-03-10 |
| AU2010344330B2 (en) | 2014-11-13 |
| BR112012018626A8 (pt) | 2017-12-19 |
| BR112012018626A2 (pt) | 2016-05-03 |
| ITMI20100121A1 (it) | 2011-07-29 |
| US20120302633A1 (en) | 2012-11-29 |
| CN102665712A (zh) | 2012-09-12 |
| CN102665712B (zh) | 2013-10-16 |
| EP2528599B1 (en) | 2014-05-21 |
| CA2780432C (en) | 2017-02-21 |
| CY1115409T1 (el) | 2017-01-04 |
| CA2780432A1 (en) | 2011-08-04 |
| EP2528599A1 (en) | 2012-12-05 |
| WO2011092556A1 (en) | 2011-08-04 |
| KR20120123259A (ko) | 2012-11-08 |
| KR101723532B1 (ko) | 2017-04-06 |
| AU2010344330A1 (en) | 2012-05-24 |
| SI2528599T1 (sl) | 2014-09-30 |
| IT1397912B1 (it) | 2013-02-04 |
| US8518988B2 (en) | 2013-08-27 |
| DK2528599T3 (da) | 2014-06-30 |
| PL2528599T4 (pl) | 2014-11-28 |
| RU2552354C2 (ru) | 2015-06-10 |
| PT2528599E (pt) | 2014-07-18 |
| ES2489467T3 (es) | 2014-09-02 |